PRODUCT SHORT DESCRIPTION

Syn-AKE 200mg is a synthetic tripeptide derivative designed to mimic the neuromuscular blocking activity found in the venom of the Temple Viper (Tropidolaemus wagleri). This 200mg topical research compound is utilized to study antagonistic effects on nicotinic acetylcholine receptors in advanced tissue models.

Introduction to Syn-AKE 200mg

Syn-AKE 200mg (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a sophisticated, synthetic peptide engineered for high-resolution dermatological and neuromuscular research. Developed as a reversible antagonist of the nicotinic acetylcholine receptor (mnAChR), Syn-AKE is modeled after the active molecular sequence of Waglerin-1. This 200mg presentation from USA PEPTIDE SCIENCES allows researchers to investigate the modulation of muscle contraction and cellular signaling in a controlled in vitro environment. By targeting the postsynaptic membrane, this compound provides a precise tool for observing the inhibition of synaptic transmission without the complexities associated with biological venoms.

Research Overview: Neuromuscular Signaling and Acetylcholine Inhibition

The primary scientific value of Syn-AKE 200mg lies in its high affinity for the epsilon subunit of the nicotinic acetylcholine receptor. By binding to this receptor, the peptide prevents acetylcholine from triggering depolarization at the neuromuscular junction, effectively maintaining the muscle cell in a relaxed state.

Current laboratory investigations for Syn-AKE include:

Neuromuscular Junction (NMJ) Modeling: Analyzing the speed and reversible nature of receptor binding in synthetic muscle fibers.
Cytoskeletal Relaxation Studies: Observing the impact of inhibited contraction on the longevity and structural integrity of the extracellular matrix.
Receptor Antagonism Kinetics: Evaluating the competitive inhibition of acetylcholine in the presence of various concentrations of Syn-AKE.
Topical Permeation Dynamics: Studying the molecular behavior and localized concentration of the tripeptide when applied to lipid-based laboratory skin membranes.

Quality Standards & Analytical Testing

Integrity in laboratory reagents is paramount at USA PEPTIDE SCIENCES. Every batch of Syn-AKE 200mg is subjected to an exhaustive validation process to ensure the highest scientific standards. We utilize High-Performance Liquid Chromatography (HPLC) to confirm a purity profile of ≥99%, ensuring that no residual reagents or contaminants interfere with your experimental data. Furthermore, Mass Spectrometry (MS) is conducted to verify the precise molecular weight and identity of the Dipeptide Diaminobutyroyl Benzylamide Diacetate sequence. A comprehensive Certificate of Analysis (COA) is provided with each order to guarantee reproducibility.

Storage and Handling Requirements

To preserve the chemical stability of Syn-AKE 200mg, the lyophilized powder should be stored in a cool, dry environment. For long-term preservation, storage at -20°C is recommended. When prepared for topical research applications, the peptide should be dissolved in a suitable research-grade solvent or carrier. Once reconstituted, the solution should be kept refrigerated at 2°C to 8°C and protected from direct UV light and high temperatures to prevent the degradation of the peptide bonds and the benzylamide moiety.

Research Use Disclaimer

The compounds provided by USA PEPTIDE SCIENCES, including Syn-AKE 200mg, are strictly for laboratory research purposes only. These products are not for human or veterinary use, nor are they intended for use in finished consumer cosmetics or medical devices. All handling and experimentation must be performed by qualified scientific professionals in a controlled and appropriate research facility.